Neopanaxadiol
CAS No. 1203590-03-7
Neopanaxadiol( ——— )
Catalog No. M38681 CAS No. 1203590-03-7
Neopanaxadiol, an aglycone of protopanaxadiol type ginsenosides, has the potential for Alzheimer's disease research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1408 | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeopanaxadiol
-
NoteResearch use only, not for human use.
-
Brief DescriptionNeopanaxadiol, an aglycone of protopanaxadiol type ginsenosides, has the potential for Alzheimer's disease research.
-
DescriptionNeopanaxadiol, an aglycone of protopanaxadiol type ginsenosides, has the potential for Alzheimer's disease research.
-
In Vitro———
-
In VivoNeopanaxadiol (30 mg/kg; oral) has a T1/2 of 2.52 hours, a CL of 5.44 L/h?kg, a Cmax of 913.44 ng/mL in dogs.
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number1203590-03-7
-
Formula Weight460.743
-
Molecular FormulaC30H52O3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cong Geng, et al. Development and validation of an UPLC-Q/TOF-MS assay for the quantitation of neopanaxadiol in beagle dog plasma: Application to a pharmacokinetic study. Biomed Chromatogr. 2017 May;31(5).?
molnova catalog
related products
-
Oxepinac
oxepinac is an effective and well-tolerated compound for the treatment of painful osteoarthritis. oxepinac has no teratogenic effect on mouse and rabbit fetuses in animal experiments.
-
Lys(Boc)-Leu-Lys(Boc...
Lys(Boc)-Leu-Lys(Boc)-OBzl
-
Tolycaine
Tolycaine is a compound of local anesthetic.
Cart
sales@molnova.com